2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C

计划入组 390 人 · 首次发布于 2019 年 7 月 9 日

Retrospective Analysis of Patients Implanted With 2 Levels of Prodisc® C Vivo Devices

计划入组 200 人 · 首次发布于 2026 年 1 月 27 日

Clinical and Radiological Outcomes: Two-level Cervical ProDisc-C Vivo Versus Hybrid Construct.

计划入组 542 人 · 首次发布于 2017 年 12 月 8 日

SK-1404

SK-08

SK-09

C & C Oxygen Company

United States

SK Life Science, Inc.

United States

SK bioscience Co., Ltd.

South Korea

Centinel Spine Achieves FDA Approval for Two-Level Cervical Disc Replacement with Record-Breaking Clinical Success Rate

SK Biopharmaceuticals Licenses Preclinical LRRK2/c-Abl Dual Inhibitor 1ST-104 for Parkinson's in Deal Worth Up to $314.8M

AI Accelerates Cancer Drug Discovery: SK Telecom and SK Biopharmaceuticals Identify ROR1-Targeting Compounds in Five Months